Elsevier

Atherosclerosis

Volume 143, Issue 1, March 1999, Pages 1-6
Atherosclerosis

Review article
Chronic infection in the aetiology of atherosclerosis—focus on Chlamydia pneumoniae

https://doi.org/10.1016/S0021-9150(98)00317-7Get rights and content

Abstract

An inflammatory basis to atherosclerosis is now accepted. It remains plausible (but unproven) that common infectious agents may contribute to the inflammatory signal, and hence the development (and/or progression of atherosclerosis and its clinical sequelae. Of the candidate microorganisms implicated, Chlamydia pneumoniae has emerged as the most likely pathogen to have a casual role. Evidence for this is based on sero-epidemiological, pathological and laboratory-based evidence, in addition to early animal models and small-scale antibiotic studies. A past decade of research has now culminated in prospective antibiotic intervention trials in coronary heart disease to be conducted. The results of these studies should help to finally determine whether infection with C. pneumoniae is a pathogenetic factor in atherosclerosis, and whether antibiotic therapy has a role in the secondary prevention of coronary heart disease.

Introduction

Atherosclerosis and related diseases, in particular myocardial infarction (MI) and coronary heart disease (CHD) are a major cause of morbidity and mortality worldwide. Differences in the prevalence of conventional cardiovascular risk factors (such as smoking, hypertension and dyslipidaemia) do not account fully for temporal and geographical variations in the prevalence or severity of CHD [1], [2]. Consequently, there is intense research interest focused on seeking other atherogenic risk factors.

The potential role of common infectious agents in the pathogenesis and progression of atherosclerosis has been studied increasingly over the last decade. The evidence for Chlamydia pneumoniae as a potential causative agent is strongest, and is based on findings of numerous sero-epidemiological studies, examination of atheromatous plaque specimens, in-vitro animal models and recently, pilot anti-chlamydial antibiotic intervention trials. This review aims to discuss the evidence implicating C. pneumoniae as an aetiological agent in atherogenesis—highlighting both current knowledge and possible further lines of investigation.

The widely accepted ‘response to injury’ hypothesis of atherosclerosis proposes that an initial insult to the arterial wall triggers atherogenesis and plaque formation [3]. It is also recognised that ‘plaque activity’ and the function of the cellular components can be a more important determinant the clinical manifestations of atherosclerosis than is the degree of stenosis of arterial lesions [4]. Although many factors may initiate atherogenesis, the process ultimately involves an inflammatory state in which macrophages and T lymphocytes play a major role [5]. Antigen within the plaque may trigger/perpetrate the immunological activity and therefore the atherogenic inflammation. Suggested antigenic stimuli include modified LDL-cholesterol [6], but also components of intracellular pathogens such as cytomegalovirus (CMV) and C. pneumoniae.

Section snippets

Candidate infective agents and atherogenesis

In the 1970s, animal experiments showed that avian herpesvirus infection resulted in intense fibro-lipid deposition within major arterial walls of affected birds; these lesions closely resembled atherosclerosis [7]. Vaccination before exposure to the virus prevented formation of such lesions [8]. Herpes simplex virus has not generally been associated with human cardiovascular disease in epidemiological studies [9], but CMV, another common herpesvirus, has been linked to some forms of vascular

Sero-epidemiology

In 1988, Saikku and co-workers, provided the first evidence suggesting a role of C. pneumoniae [25] in CHD. Elevated antibodies to C. pneumoniae and immune complexes containing C. pneumoniae antigen were detected in patients with acute MI and chronic CHD. The investigators postulated that acute MI might be linked to an exacerbation of chronic C. pneumoniae infection. More recently, Danesh et al. [14] reviewed 18 published sero-epidemiological studies (involving about 2700 cases). They showed

C. pneumoniae and CHD: a current perspective

Over the last decade, about 70–80 published studies (conducted in 18 different countries) have shown a positive association between C. pneumoniae and CHD (Table 1). The research—both clinically-orientated and laboratory-based—has now intensified. The focus now is on establishing whether C. pneumoniae plays a causative role in the pathogenesis of atherosclerosis (and CHD), and whether anti-chlamydial antibiotics have a protective benefit against secondary cardiovascular events.

A clear mechanism

Conclusions

A significant pathogenetic role of C. pneumoniae in atherosclerosis and CHD is plausible, but unproven. Investigators in different institutions studying patients at various stages of CHD, have consistently identified a link between positive anti-C. pneumoniae antibody serology (or the presence of C. pneumoniae DNA/protein) and atherosclerotic disease. Reports of infection-induced atherosclerosis in animal models in addition to ‘live’ intact C. pneumoniae organisms being isolated from human

References (73)

  • M.A. Mendall et al.

    Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease

    J Infect

    (1995)
  • E. Gurfinkel et al.

    Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study

    Lancet

    (1997)
  • G.H. Dahlén et al.

    Lipoprotein(a), IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease

    Atherosclerosis

    (1995)
  • M. Maass et al.

    Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease

    J Am Coll Cardiol

    (1998)
  • S.A. Saboor et al.

    Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction

    Lancet

    (1992)
  • M.S. Nieminen et al.

    Infection and inflammation as risk factors for myocardial infarction

    Eur Heart J

    (1993)
  • J.A. Farmer et al.

    Dyslipidaemia and other risk factors for coronary artery disease

  • R. Ross

    The pathogenesis of atherosclerosis: a perspective for the 1990s

    Nature

    (1993)
  • G.K. Hansson

    Immune mechanisms in atherosclerosis

    Atherosclerosis

    (1989)
  • D. Steinberg et al.

    Modifications of low-density lipoprotein that increases its atherogenicity

    New Engl J Med

    (1989)
  • C.G. Fabricant et al.

    Virus-induced atherosclerosis

    J Exp Med

    (1978)
  • C.G. Fabricant et al.

    Herpesvirus-induced atherosclerosis in chickens

    Fed Proc

    (1983)
  • R.J. Havlik et al.

    Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Heart Study

    Arteriosclerosis

    (1989)
  • Y.F. Zhou et al.

    Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy

    New Engl J Med

    (1996)
  • A. Kol et al.

    Cytomegalovirus replication is not a cause of instability in unstable angina

    Circulation

    (1995)
  • M.A. Mendall et al.

    Relation of Helicobacter pylori infection and coronary heart disease

    Br Heart J

    (1994)
  • L.J. Murray et al.

    Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class

    Br Heart J

    (1995)
  • P.H. Whincup et al.

    Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men

    Heart

    (1996)
  • N.J. Wald et al.

    Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study

    Br. Med. J.

    (1997)
  • P. Patel et al.

    Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

    Br. Med. J.

    (1995)
  • F. Parente et al.

    Helicobacter pylori infection and coagulation in healthy people

    Br. Med. J.

    (1997)
  • F. Blasi et al.

    Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms

    J Clin Microbiol

    (1996)
  • K.J. Mattila et al.

    Association between dental health and acute myocardial infarction

    Br. Med. J.

    (1989)
  • S.P. Wang et al.

    Microimmunofluorescence serology in Chlamydia trachomatis

  • S. Gupta et al.

    Chlamydia pneumoniae and coronary heart disease: coincidence, association or causation?

    Br. Med. J.

    (1997)
  • A. Shor et al.

    Detection of Chlamydia pneuomoniae in coronary arterial fatty streaks and atheromatous plaques

    South Afr Med J

    (1992)
  • Cited by (0)

    Modification of ‘The John French Memorial Lecture’, delivered at the British Atherosclerosis Society Meeting, Oxford, UK, on 2nd April 1998.

    View full text